The Effect of a Multivitamin in the Treatment of Memory Loss in Postmenopausal Women

Exclusion Criteria

• •Individuals who meet at least one of the following criteria will be excluded from the study:
• •1. Complaints of hot flashes, insomnia and / or very intense sleep disorders, at the discretion of the investigator.
• •2. Presence of moderate to severe depression, score ≥ 18 at assessment through the Beck Depression Inventory. ,
• •3. Presence of moderate to severe anxiety, with a ≥ 30 score on the Beck anxiety inventory. ,
• •4. Initiation of hormone replacement therapy in the 6 months prior to study inclusion. Patients receiving hormone replacement therapy starting more than 6 months before inclusion in the study may be included in the study provided that the treatment is regular with the same drug and the same dose during the last 6 months before inclusion and provided that this treatment is maintained throughout the study.
• •5. Use of psychotropic medications (anticonvulsants, benzodiazepines, antipsychotics), selective serotonin reuptake inhibitors (SSRIs) and selective serotonin and noradrenaline reuptake inhibitors (SSRIs)
• •6. Alcoholism and / or use of other illicit drugs.
• •7. History of allergy or intolerance to any component of the experimental product formulation.
• •8. Diagnosis of neurological diseases associated with cognitive deficits (including dementia and mental retardation) or psychiatric illnesses.
• •9. Presence of serious or uncontrolled diseases (such as decompensated hypothyroidism) at the discretion of the researcher (such as stroke, Parkinson's disease, etc.).
• •10. Participation in clinical research protocol in the previous 12 months unless, at the discretion of the researcher, their participation in the study may incur direct benefit to the research participant.
• •11. Presence of any condition that, at the discretion of the researcher, makes the patient unfit to participate in the study.